CVMP opinions on veterinary medicinal products

Under Regulation (EC) No 726/2004

The Committee adopted by consensus a positive opinion for a marketing authorisation of Newflend ND H9, from Ceva-Phylaxia Co. Ltd., a new vaccine for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs against Newcastle disease and H9 low pathogenic avian influenza.

Under Regulation (EU) 2019/6

The Committee adopted by consensus positive opinions for variations requiring assessment concerning quality-related changes for:

• Bravecto
• Kriptazen
• Leucofeligen FeLV/RCP
• Masivet
• Nexgard Combo
• Prevomax
• Suprelorin

The Committee adopted by consensus positive opinions for variations requiring assessment to align the product information with version 9.0 of the QRD template for:

• Bravecto
• Innovax-ILT
• Nobilis Influenza H5N2
• Porcilis PCV M Hyo
• Poulvac E. coli
• Purevax Rabies
• Stronghold
• Versican Plus L4
• Versican Plus Pi
• Versican Plus Pi/L4

Scientific advice

The Committee adopted 4 scientific…